CDKL3 is a targetable regulator of cell cycle progression in cancers-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CDKL3 is a targetable regulator of cell cycle progression in cancers

Published:2024-07-04 Issue:16 Volume:134 Page:
ISSN:1558-8238
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Zhang Haijiao,Lin Jiahui,Zheng Shaoqin,Ma Lanjing,Pang Zhongqiu,Yin Hongyi,Meng Chengcheng,Wang Yinuo,Han Qing,Zhang Xi,Li Zexu,Cao Liu,Liu Lijun,Fei Teng,Gao Daming,Yang Liang,Peng Xueqiang,Ding Chen,Wang Shixue,Sheng Ren^ORCID

Funder

National Natural Science Foundation of China

Fundamental Research Fund for the Central Universities

Liaoning Revitalization Talents Program

Fundamental Research Funds for the Central Universities

Publisher

American Society for Clinical Investigation

Link

https://www.jci.org/articles/view/178428/files/pdf

Reference63 articles.

1. The cell cycle in stem cell proliferation, pluripotency and differentiation

2. Cell cycle, CDKs and cancer: a changing paradigm

3. Cdks, cyclins and CKIs: roles beyond cell cycle regulation

4. Mammalian cell-cycle regulation: several Cdks, numerous cyclins and diverse compensatory mechanisms

5. CDC7-independent G1/S transition revealed by targeted protein degradation

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP